Keyphrases
Placebo
100%
Bone Turnover Markers
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic Patients
100%
Metformin
100%
Insulin Analogues
100%
Procollagen Type 1 N-terminal Propeptide (P1NP)
100%
Insulin
70%
C-reactive Protein
20%
Body Mass Index
20%
Bone Turnover
20%
Insulin Dose
20%
Bone Resorption
20%
Placebo-controlled
10%
Insulin Therapy
10%
Hemoglobin A1c (HbA1c)
10%
Between-group Difference
10%
Human Studies
10%
Double-blind Trial
10%
Bone Formation
10%
Glycated Hemoglobin A1c
10%
Treatment-naïve
10%
C-terminal Telopeptide of Type I Collagen
10%
Type I Procollagen
10%
Osteoanabolic
10%
Biochemistry, Genetics and Molecular Biology
Insulin Analog
100%
Osteolysis
100%
Ossification
100%
C-Reactive Protein
66%
Bone Turnover
66%
Body Mass
66%
Glycosylated Hemoglobin
33%
N-Terminus
33%
Glycated Hemoglobin
33%
Preclinical Study
33%
Human Study
33%
Type I Collagen
33%
C-Terminal Telopeptide
33%
Medicine and Dentistry
Placebo
100%
Maturity Onset Diabetes of the Young
100%
Insulin Derivative
100%
Glycon
100%
Patient with Type 2 Diabetes
100%
Osteolysis
30%
Ossification
30%
C Reactive Protein
20%
Body Mass Index
20%
Bone Turnover
20%
Amino Terminal Sequence
10%
Hemoglobin A1c
10%
Insulin Treatment
10%
Human Study
10%
Collagen Type 1
10%
C-Terminal Telopeptide
10%
Procollagen
10%
Immunology and Microbiology
Osteolysis
100%
Ossification
100%
C-Reactive Protein
66%
Body Mass
66%
Bone Turnover
66%
Amino Terminal Sequence
33%
Carboxy Terminal Sequence
33%
Preclinical Study
33%